In contrast, and in the setting of maternal immunocompetence, mitochondrial antiviral-signaling (MAVS) protein-dependent type I IFN signaling in the fetus was found to be necessary to restrict ZIKV infection in the fetal compartment of the placenta (57). This evidence concerns the gene MAVS and Zika virus infectious disease.